Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up.

CONCLUSION: HRQoL of VVS patients improves over time after enrolling in a clinical trial, even with recurrent faints or randomization to placebo. Improvements may result from alternative factors, such as interaction with experts or patient adjustment. PMID: 31122600 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31122600?dopt=Abstract

Source: Autonomic Neuroscience - May 29, 2019 Category: Neuroscience Authors: Ng J, Sheldon RS, Maxey C, Ritchie D, Raj V, Exner DV, Raj SR Tags: Auton Neurosci Source Type: research